DRD4 anticorps (C-Term)
Aperçu rapide pour DRD4 anticorps (C-Term) (ABIN7184800)
Antigène
Voir toutes DRD4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the C-terminal region of Human D4DR.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:2000, IF:1:200-1:1000, ELISA:1:40000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- DRD4 (Dopamine Receptor D4 (DRD4))
-
Autre désignation
- DRD4
-
Sujet
- D(2C) dopamine receptor antibody, D(4) dopamine receptor (D(2C) dopamine receptor). antibody, D(4) dopamine receptor antibody, D4 dopamine receptor antibody, D4DR antibody, Dopamine D4 receptor antibody, DRD 4 antibody, Drd4 antibody, DRD4_HUMAN antibody
-
UniProt
- P21917
-
Pathways
- cAMP Metabolic Process, Synaptic Membrane, Proton Transport, Photoperiodism, Negative Regulation of Transporter Activity
Antigène
-